Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / March 12, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Cellect Biotechnology Ltd. (NASDAQ: APOP) is a biotechnology company, foc...
Gainers: Globus Maritime (NASDAQ: GLBS ) +84% . Organogenesis Holdings (NASDAQ: ORGO ) +61% . Yatra Online (NASDAQ: YTRA ) +37% . Axovant Sciences (NASDAQ: AXGT ) +31% . Bio-Path Holdings (NASDAQ: BPTH ) +27% . Seres Therapeutics (NASDAQ: MCRB ) +27% . Phunware (NASDAQ: PHUN ) ...
CORAL GABLES, FL / ACCESSWIRE / March 11, 2019 / The future of the healthcare stock market, and the medical sector in its entirety, is largely dependent on whether medical experts and healthcare professionals are aptly prepared to meet the growing demands of patients. According to recent p...
Globus Maritime (NASDAQ: GLBS ) +109% . More news on: Globus Maritime Limited, Axovant Sciences Ltd., Pyxis Tankers Inc., Stocks on the move, Read more ...
Cellect Biotechnology (NASDAQ: APOP ) reports positive preliminary results from its collaboration with Cell2in, a privately-held South Korean company. More news on: Cellect Biotechnology Ltd., Healthcare stocks news, Stocks on the move, Read more ...
TEL AVIV, Israel , March 11, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced positive preliminary results from its collaboration with Cell2in, a privately-held South Korean company focused on improving...
Tel Aviv, Israel, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced the closing of its previously announced $6.5 million underwritten public offering of 1,889,000 units, with each unit consist...
MagneGas Applied Technology Solutions (NASDAQ: MNGA ) -46% . More news on: MagneGas Corporation, Cellect Biotechnology Ltd., Biocept, Inc., Stocks on the move, Read more ...
Cellect Biotechnology (NASDAQ: APOP ) prices its public offering of 1,889,000 units, with each unit consisting of one ADS and a warrant to purchase one ADS as well as 2,444,800 pre-funded units. More news on: Cellect Biotechnology Ltd., Healthcare stocks news, Read more ...
Tel Aviv, Israel, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced the pricing of an underwritten public offering of 1,889,000 units, with each unit consisting of one American Depositary Shar...
News, Short Squeeze, Breakout and More Instantly...
Cellect Biotechnology Ltd. Company Name:
APOP Stock Symbol:
NASDAQ Market:
Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs”) to be distributed in connection with the...
Cellect Biotechnology Ltd (NASDAQ: APOP) shareholders approved the previously announced strategic merger agreement with Quoin Pharmaceuticals, the company said in a press release on Monday. Shares of the Israel-headquartered firm jumped about 50% this morning. The stock has now ...